Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$2.48 - $9.65 $30,806 - $119,872
12,422 Added 15724.05%
12,501 $120,000
Q3 2023

Nov 01, 2023

SELL
$2.37 - $4.63 $3,133 - $6,120
-1,322 Reduced 94.36%
79 $0
Q2 2023

Aug 04, 2023

BUY
$3.47 - $5.33 $3,268 - $5,020
942 Added 205.23%
1,401 $6,000
Q1 2023

Apr 27, 2023

BUY
$3.03 - $5.13 $1,390 - $2,354
459 New
459 $1,000
Q3 2022

Nov 04, 2022

BUY
$2.0 - $3.56 $200 - $356
100 New
100 $0
Q3 2021

Oct 28, 2021

BUY
$7.83 - $9.41 $1,190 - $1,430
152 Added 11.62%
1,460 $11,000
Q2 2021

Aug 12, 2021

BUY
$7.97 - $10.66 $10,424 - $13,943
1,308 New
1,308 $10,000

Others Institutions Holding FUSN

About Fusion Pharmaceuticals Inc.


  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.